Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Hippuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.68 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.68 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.68 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | PTPRC | P08575 | 2/20 | 0.57 |
| ▸ | CTSL | P07711 | 1/20 | 0.57 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hippuric Acid SCHEMBL428479 | 1.00 | GAA (0.68) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| SCHEMBL22030672 | 1.00 | GAA (0.68) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| Hippuric Acid SCHEMBL3448563 | 0.98 | MAPT (0.66) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| Hippuric Acid SCHEMBL15416338 | 0.98 | MAPT (0.66) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| Hippuric Acid SCHEMBL11656206 | 0.98 | MAPT (0.66) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| Hippuric Acid SCHEMBL11709120 | 0.98 | MAPT (0.66) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| Hippuric Acid SCHEMBL8165809 | 0.98 | MAPT (0.66) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| Hippuric Acid SCHEMBL21569381 | 0.98 | MAPT (0.66) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| Hippuric Acid SCHEMBL657588 | 0.98 | KDM4E (0.66) | GAAMAPTKDM4EHIF1ASLC22A6 | |
| Hippuric Acid SCHEMBL7398337 | 0.98 | MAPT (0.66) | GAAMAPTKDM4EHIF1ASLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 41332 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-12638455-B2 | Kidney health monitoring in hypertension patients | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-26 | — | — | US | claimed |
| WO-2026103747-A1 | SALT OF THIAZOLE DERIVATIVE INHIBITOR, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏豪森药业集团有限公司 | 2026-05-21 | — | — | WO | claimed |
| EP-4745138-A1 | THIO-GLUTARIMIDO ISOINDOLINONE DERIVATIVE, BIFUNCTIONAL PROTEIN DEGRADER CONTAINING SAME, AND USES THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| EP-4745135-A1 | COMPOUND BASED ON THIO-GLUTARIMIDO ISOINDOLINONE SKELETON AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| EP-4745137-A1 | GLUTARIMIDE ISOINDOLINONE SKELETON-BASED COMPOUND | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-122070278-A | Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof | 标新生物医药科技(上海)有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122036704-A | Free base crystal form or acid salt of biaryl compound, preparation method and medical application thereof | 江苏豪森药业集团有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-12624050-B2 | Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2026-05-12 | — | — | US | claimed |
| US-4414145-A | Preparation and use of a 195M-AU-containing liquid | BYK-MILLINKCRODT CIL B.V. (NL) | 1983-11-08 | — | — | US | claimed |
| US-4292162-A | A SOLUTION OF TRIS BUFFER, HIPPURIC ACID, AND A WATER-SOLUBLE HIPPURATE | GELMAN SCIENCES, INC. (US) | 1981-09-29 | — | — | US | claimed |
| US-4292154-A | USING A UREA-, AN AMIDE-, OR AMINOCARBOAMIDE-CONTAINING CARBOXYLIC ACID AND THE CORRESPONDING ACID SALT | GELMAN SCIENCES, INC. (US) | 1981-09-29 | — | — | US | claimed |
| US-4284647-A | ADMINISTERING BENZOIC OR PHENYLACETIC ACID | THE JOHNS HOPKINS UNIVERSITY (US) | 1981-08-18 | — | — | US | claimed |
| EP-0029284-A1 | Method for the electrophoretic separation of proteins, a buffer solution and buffer compositions therefor | GELMAN SCIENCES, INC. (US) | 1981-05-27 | — | — | EP | claimed |
| US-4256731-A | COMPRISING A CATIONIC MICROBIOCIDE AND A QUATERNARY AMMONIUM COMPOUND ALONG WITH INHIBITION DISCOLORATION-COMPOUNDS WHICH INCLUDE A NONIONIC SURFACTANT AND AN AMINO ACID OR A DI- OR TRICARBOXYLIC ACID | BEECHAM, INC. (US) | 1981-03-17 | — | — | US | claimed |
| US-4243749-A | Immunoassay employing an enzyme label | MILES YEDA LTD. (IL) | 1981-01-06 | — | — | US | claimed |
| US-4148912-A | ANTISECRETORY, ANTIULCER | SCIENCE UNION ET CIE (FR) | 1979-04-10 | — | — | US | claimed |
| US-4108726-A | Sarcoidosis test | RESEARCH CORPORATION (US) | 1978-08-22 | — | — | US | claimed |
| US-3990955-A | Electrodeposition of hard nickel | THE INTERNATIONAL NICKEL COMPANY, INC. (US) | 1976-11-09 | — | — | US | claimed |